Annual CFI
$135.05 M
+$302.18 M+180.81%
31 December 2023
Summary:
Astria Therapeutics annual cash flow from investing activities is currently $135.05 million, with the most recent change of +$302.18 million (+180.81%) on 31 December 2023. During the last 3 years, it has risen by +$128.75 million (+2043.68%). ATXS annual CFI is now at all-time high.ATXS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$6.19 M
+$74.29 M+109.09%
30 September 2024
Summary:
Astria Therapeutics quarterly cash flow from investing activities is currently $6.19 million, with the most recent change of +$74.29 million (+109.09%) on 30 September 2024. Over the past year, it has increased by +$6.19 million (+154800.00%). ATXS quarterly CFI is now -96.83% below its all-time high of $194.99 million, reached on 31 March 2023.ATXS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$190.16 M
+$6.19 M+3.15%
30 September 2024
Summary:
Astria Therapeutics TTM cash flow from investing activities is currently -$190.16 million, with the most recent change of +$6.19 million (+3.15%) on 30 September 2024. Over the past year, it has dropped by -$192.05 million (-10172.14%). ATXS TTM CFI is now -240.81% below its all-time high of $135.05 million, reached on 31 December 2023.ATXS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATXS Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +180.8% | +10000.0% | -10000.0% |
| 3 y3 years | +2043.7% | +100.0% | -3055.1% |
| 5 y5 years | +716.5% | -54.7% | -10000.0% |
ATXS Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +180.8% | -96.8% | +104.6% | -240.8% | +3.1% |
| 5 y | 5 years | at high | +180.8% | -96.8% | +104.6% | -240.8% | +3.1% |
| alltime | all time | at high | +180.8% | -96.8% | +104.6% | -240.8% | +3.1% |
Astria Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.19 M(-109.1%) | -$190.16 M(-3.2%) |
| June 2024 | - | -$68.10 M(-46.0%) | -$196.35 M(+5.5%) |
| Mar 2024 | - | -$126.23 M(+6161.5%) | -$186.17 M(-237.9%) |
| Dec 2023 | $135.05 M(-180.8%) | -$2.02 M(>+9900.0%) | $135.05 M(+7053.2%) |
| Sept 2023 | - | -$4000.00(-100.0%) | $1.89 M(-50.9%) |
| June 2023 | - | -$57.92 M(-129.7%) | $3.84 M(-93.0%) |
| Mar 2023 | - | $194.99 M(-244.2%) | $54.96 M(-132.9%) |
| Dec 2022 | -$167.13 M(+1231.2%) | -$135.18 M(-7032.3%) | -$167.13 M(+135.6%) |
| Sept 2022 | - | $1.95 M(-128.7%) | -$70.95 M(-2.7%) |
| June 2022 | - | -$6.80 M(-74.9%) | -$72.90 M(+10.3%) |
| Mar 2022 | - | -$27.10 M(-30.5%) | -$66.10 M(+426.5%) |
| Dec 2021 | -$12.55 M(-299.3%) | -$39.00 M(<-9900.0%) | -$12.55 M(-295.1%) |
| Sept 2021 | - | $0.00(0.0%) | $6.43 M(-23.7%) |
| June 2021 | - | $0.00(-100.0%) | $8.44 M(-82.5%) |
| Mar 2021 | - | $26.45 M(-232.2%) | $48.18 M(+664.7%) |
| Dec 2020 | $6.30 M(-254.3%) | -$20.01 M(-1100.5%) | $6.30 M(-72.4%) |
| Sept 2020 | - | $2.00 M(-95.0%) | $22.81 M(-33.8%) |
| June 2020 | - | $39.74 M(-357.5%) | $34.46 M(-2040.1%) |
| Mar 2020 | - | -$15.43 M(+340.4%) | -$1.78 M(-56.5%) |
| Dec 2019 | -$4.08 M | -$3.50 M(-125.7%) | -$4.08 M(-891.1%) |
| Sept 2019 | - | $13.65 M(+289.0%) | $516.00 K(-101.4%) |
| June 2019 | - | $3.51 M(-119.8%) | -$36.14 M(-8.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$17.74 M(-1721.4%) | -$39.64 M(+81.0%) |
| Dec 2018 | -$21.91 M(-247.2%) | $1.09 M(-104.8%) | -$21.91 M(-4.8%) |
| Sept 2018 | - | -$23.01 M(<-9900.0%) | -$23.00 M(>+9900.0%) |
| June 2018 | - | $8000.00(>+9900.0%) | -$10.00 K(-44.4%) |
| Mar 2018 | - | $0.00(0.0%) | -$18.00 K(-100.1%) |
| Dec 2017 | $14.88 M(-196.1%) | $0.00(-100.0%) | $14.88 M(-28.1%) |
| Sept 2017 | - | -$18.00 K(<-9900.0%) | $20.69 M(+12.6%) |
| June 2017 | - | $0.00(-100.0%) | $18.38 M(-35.5%) |
| Mar 2017 | - | $14.90 M(+156.5%) | $28.48 M(-283.9%) |
| Dec 2016 | -$15.49 M(+3579.3%) | $5.81 M(-349.5%) | -$15.49 M(-28.5%) |
| Sept 2016 | - | -$2.33 M(-123.1%) | -$21.66 M(+11.9%) |
| June 2016 | - | $10.10 M(-134.7%) | -$19.36 M(-34.3%) |
| Mar 2016 | - | -$29.07 M(+7952.4%) | -$29.46 M(+6898.8%) |
| Dec 2015 | -$421.00 K(+84.6%) | -$361.00 K(+1344.0%) | -$421.00 K(-108.7%) |
| Sept 2015 | - | -$25.00 K(+150.0%) | $4.85 M(-4672.6%) |
| June 2015 | - | -$10.00 K(-60.0%) | -$106.00 K(-55.6%) |
| Mar 2015 | - | -$25.00 K(-100.5%) | -$239.00 K(+4.8%) |
| Dec 2014 | -$228.00 K(+430.2%) | $4.91 M(-198.6%) | -$228.00 K(-95.6%) |
| Sept 2014 | - | -$4.98 M(+3381.1%) | -$5.13 M(+3170.7%) |
| June 2014 | - | -$143.00 K(+921.4%) | -$157.00 K(+1021.4%) |
| Mar 2014 | - | -$14.00 K | -$14.00 K |
| Dec 2013 | -$43.00 K | - | - |
FAQ
- What is Astria Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Astria Therapeutics?
- What is Astria Therapeutics annual CFI year-on-year change?
- What is Astria Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Astria Therapeutics?
- What is Astria Therapeutics quarterly CFI year-on-year change?
- What is Astria Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Astria Therapeutics?
- What is Astria Therapeutics TTM CFI year-on-year change?
What is Astria Therapeutics annual cash flow from investing activities?
The current annual CFI of ATXS is $135.05 M
What is the all time high annual CFI for Astria Therapeutics?
Astria Therapeutics all-time high annual cash flow from investing activities is $135.05 M
What is Astria Therapeutics annual CFI year-on-year change?
Over the past year, ATXS annual cash flow from investing activities has changed by +$302.18 M (+180.81%)
What is Astria Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ATXS is $6.19 M
What is the all time high quarterly CFI for Astria Therapeutics?
Astria Therapeutics all-time high quarterly cash flow from investing activities is $194.99 M
What is Astria Therapeutics quarterly CFI year-on-year change?
Over the past year, ATXS quarterly cash flow from investing activities has changed by +$6.19 M (+154800.00%)
What is Astria Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ATXS is -$190.16 M
What is the all time high TTM CFI for Astria Therapeutics?
Astria Therapeutics all-time high TTM cash flow from investing activities is $135.05 M
What is Astria Therapeutics TTM CFI year-on-year change?
Over the past year, ATXS TTM cash flow from investing activities has changed by -$192.05 M (-10172.14%)